首页> 外国专利> USE OF AT LEAST ONE DRUG BASED ON LICORICE, ANTIDOTE OBTAINED FROM IT, AND APPLICATION OF SPECIFIED ANTIDOTE

USE OF AT LEAST ONE DRUG BASED ON LICORICE, ANTIDOTE OBTAINED FROM IT, AND APPLICATION OF SPECIFIED ANTIDOTE

机译:使用至少一种基于甘草的药物,从中获得的解毒剂,并应用指定的解毒剂

摘要

FIELD: toxicology.;SUBSTANCE: group of inventions relates to the use of means to reduce the toxic effect of at least one polypeptide fungitoxin selected from enniatin A, enniatin A1, enniatin B, enniatin B1, enniatin B2 or enniatin B3, bovericin and apicidin, in agricultural products. The use of at least one licorice preparation selected from a group including flour, water extract, water/ethanol extract, water dry extract and water/ethanol dry extract from a whole licorice plant or from licorice roots, with the licorice preparation containing 4-10 wt %/ wt. glycyrrhizic acid, optionally together with at least one excipient for oral administration, to reduce the toxic effect of at least one polypeptide fungitoxin selected from a group including enniatins selected from the group of enniatin A, enniatin A1, enniatin B, enniatin B1, enniatin B2 or enniatin B3, bovericin and apicidin, in agricultural products. The use of an antidote comprising at least one licorice preparation selected from a group including flour, water extract, water / ethanol extract, water dry extract, and water/ethanol dry extract from a whole licorice plant or from the roots, with the licorice preparation containing 4-10 wt %/ wt. glycyrrhizic acid, to obtain a drug for oral use for the prevention and/or treatment of intoxication with polypeptide fungitoxins, where intoxication with polypeptide fungitoxins is caused by polypeptide fungitoxins selected from a group including enniatin A, enniatin A1, enniatin B, enniatin B1, enniatin B2 or enniatin B3, bovericin or apicidin.. ;EFFECT: use of the above licorice preparations and antidote is effective in reducing the toxic effect of at least one polypeptide fungitoxin selected from enniatin A, enniatin A1, enniatin B, enniatin B1, enniatin B2 or enniatin B3, bovericin and apicidin, in agricultural products. ;9 cl, 7 tbl, 5 ex
机译:田间:毒理学。物质:本发明组涉及使用手段来减少选自脑内A,Enniatin A1,eNniatiN B,EnniatiN B1,EnniatiN B2或eNniatiN B3,Bovericin和Apicidin的至少一种多肽菌丝蛋白的毒性作用。 ,农产品。使用从包含面粉,水提取物,水/乙醇提取物,水干燥提取物和来自整个甘草植物或甘草根的水/乙醇干燥提取物中的至少一种甘草制剂,含有4-10的甘草制剂wt%/ wt。甘草酸,任选地与至少一种用于口服给药的赋形剂,以降低至少一种选自肌肉蛋白的至少一种多肽菌丝蛋白的毒性作用,该毒素选自脑内Aniatiin A,Enniatin A1,Enniatin B,Enniatiin B1,Enniatiin B2或Enniatiin B3,Bovericin和Apicidin,农产品。使用具有至少一种选自粉粉,水提取物,水/乙醇提取物,水干燥提取物和来自整个甘草植物的水/乙醇干燥提取物的甘草制剂的解毒剂,与甘草制备含有4-10wt%/ wt。甘草酸,得到用于口服用途的药物,用于预防和/或治疗醉酒的毒性毒素,其中用多肽菌毒毒害是由选自肌苷A,Enniatin A1,Enniatin B,Enniatiin B1,Enniatiin B1,eNniatiin B1的多肽毒毒素引起的Enniatin B2或肠苷B3,Bovericin或Apicidin ..效果:使用上述甘草制剂和解毒剂可有效降低至少一种选自肌苷A,Enniatin A1,Enniatiin B,Enniatin B1,Enniatin的毒性毒性毒素的毒性作用B2或Enniatin B3,Bovericin和Apicidin,农产品。 ; 9 cl,7 tbl,5前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号